Both Aldoa shRNAs (shAldoa.1280 and shAldoa.558) strongly reduced tumour development and prolonged survival of tumour-bearing animals in comparison to a nontargeting control shRNA (shRen) (Fig. 8c), indicating that ALDOA is essential for liver tumour development. Here, ALDOA is linked to neoplasm.